(343 days)
Not Found
No
The summary describes a phototherapy device that uses LEDs to treat neonatal hyperbilirubinemia. There is no mention of AI, ML, image processing, or any data analysis that would suggest the use of such technologies. The performance studies focus on physical characteristics like irradiance, body surface area coverage, and temperature.
Yes.
Explanation: The "Intended Use / Indications for Use" section explicitly states that the device "is intended for the treatment of neonatal hyperbilirubinemia," which is a medical condition. It is designed to provide "phototherapy treatment," indicating a therapeutic purpose.
No
The device is a phototherapy light intended for the treatment of neonatal hyperbilirubinemia, not for diagnosis. Its description and performance studies focus on delivering light for treatment, not on identifying a condition.
No
The device description clearly states it is a "portable phototherapy light" that delivers light via "blue light emitting diodes (LEDs)". This indicates it is a hardware device that emits light for treatment, not a software-only device.
Based on the provided information, the Bright Embrace Model SBL60 phototherapy light is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information for diagnosis, monitoring, or screening.
- Bright Embrace Function: The Bright Embrace Model SBL60 is a therapeutic device. It directly treats a condition (neonatal hyperbilirubinemia) by applying light to the patient's skin. It does not analyze any biological samples.
Therefore, the Bright Embrace Model SBL60 falls under the category of a therapeutic medical device, not an IVD.
N/A
Intended Use / Indications for Use
The Bright Embrace Model SBL60 phototherapy light is intended for the treatment of neonatal hyperbilirubinemia. It is designed to provide phototherapy treatment from underneath and around the neonate. The Bright Embrace can be used in a clinical setting or in the home.
Product codes
LBI
Device Description
The Bright Embrace Model SBL60 is a single-patient, portable phototherapy light that was specifically designed to incorporate these features: 1) high intensity blue light over a large body surface area as recommended by the American Academy of Pediatrics (AAP); 2) the ability to hold the newborn during treatment; 3) single patient use to minimize cross-contamination in hospitals and to facilitate home care logistics: The Bright Embrace Model SBL60 delivers a narrow band of high-intensity blue light via blue light emitting diodes (LEDs) to provide treatment for neonatal hyperbilirubinemia, also called newborn jaundice. The Bright Embrace Model SBL60 is designed to provide phototherapy treatment from a wrap-around design that provides light from underneath, the sides and partially the front of the newborn to achieve a large body surface area of treatment. The blue LEDs used in the Bright Embrace Model SBL60 emit light in the range of 430-510nm (peak wavelength 480nm). This range corresponds to the spectral absorption of light by bilirubin, and is thus considered to be the most effective for the desirable degradation of bilirubin under the exposed skin. Blue LEDs do not emit significant energy in the ultraviolet (UV) region of the spectrum, so there is no concern about UV exposure to the newborn. As with most phototherapy devices, protective eye shades or goggles must be used to protect the newborn's eyes from excessive light exposure.
Since LEDs have minimal light output degradation over 10,000 hours (with proper use), and since the Bright Embrace Model SBL60 is designed for single patient use of 60 hours of phototherapy or less, there is no significant decradation of light output over the life-span of the Bright Embrace Model SBL60.
The irradiance by the Bright Embrace Model SBL60 to the newborn's skin averages 38 uWcm²/nm - nicely in the range for "intense phototherapy" recommended by the AAP of >30 uWcm3/nm. The body surface area (BSA) treated by these lights covers 501 cm², or 21% of the BSA of an average size newborn - consistent with the AAP recommendation to treat "as much body surface area as possible."
A newborn being treated in a Bright Embrace Model SBL60 can be held for feeding or cuddling during treatment. Otherwise, it is recommended that the Bright Embrace Model SBL60 and newborn be placed in a crib or bassinette or on a warming table or in an incubator for security.
The sincle-patient design of the Bright Embrace Model SBL60 virtually eliminates the risk of cross-contamination between newborns. The newborn is swaddled in a light-transmitting. disposable non-woven spun-bound material "Softy" for comfort and cleanliness. The baby and Softy swaddling overlie a clear PVC (nonreactive) plastic tray that overlies the LEDs and the electronic circuitry including an hour meter. The back of the device is soft, flexible, nonabsorbent neoprene.
60 hours was determined to be an appropriate maximum for this single use device. Based on non-published PEP outcome studies with the similar-dose device, the PEP Ultra Bili Light, over 95% of newborns requiring phototherapy need less than 60 hours. After searching medical publications and literature available from other phototherapy device manufacturers, no other treatment times data could be found or is known.
The hour meter timing control built into the Bright Embrace Model SBL60 is simply a LCD display that shows the hours left on the machine. It is set at manufacture to 60 hours and counts backward when the unit is on until phototherapy is completed or until the timing control reaches zero hours, at which point the unit will no longer light. It's purpose is to ensure the single-patient intent of the device; it does not control or determine the treatment time of the newborn. The simple timer programming circuitry contains minimal software.
The Bright Embrace Model SBL60 system consists of 4 components: the light source, the lowvoltage power supply, disposable "Softy" swaddling material, and Bill-Goggles (or other eye protection). In addition, there are included instructions for use and a mail-back box for green recycling.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Neonates
Intended User / Care Setting
Clinical setting, home-use
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Nonclinical Testing:
A. Standards Testing:
A.1. IEC 60601-1: 2005 - This Medical Electrical Equipment Safety standard testing was completed on the Bright Embrace Model SBL60 power supply - the GlobTek Model GTM41060-2515. Switching Power Supply - by SIQ. a certified CB Testing Laboratory. The 244 page report. attached (see Attachment A.) confirms that the Bright Embrace Model SBL60 power supply meets this standard as well as the related standards as listed in the comparison chart above: UL60601-1-3.
CUL to 22.2#601, DEMKO to EN60601. CE Class II. PSE to J60950. CB Report, VCCI. EN 60601-1-2:2001, EN61000-3-2, EN61000-3-3 & EN50082-1, including EN61000-4-2, EN61000-4-3, EN61000-4-4, EN61000-4-5, EN61000-4-6, EN61000-4-11
The entire device underwent this standard testing by Intertek. The report is included as Attachment A-2.
A.2. IEC 60601-1-2: 2004 - This Electromagnetic Conduction Safety standard testing was completed on the Bright Embrace Model SBL60 device by Intertek, a certified standards testing laboratory. The report conclusions included below confirms that the Bright Embrace Model SBL60 meets this standard. The full, 55-page text of this report may be found in Attachment B.
A.3. IEC 60601-2-50: 2000/07/01 Ed:1 - Particular Requirements for the Safety of Infant (sic) Phototherapy Equipment. This Safety standard testing was completed on the Bright Embrace Model SBL60 device by Intertek, a certified standards testing laboratory. See Attachment A-3.
B. Tests Performed at Physician Engineered Products, Inc.:
B.1. Irradiance test: Lab Test Form, Product: Bright Embrace Model SBL60, Date: 6/10/11.
Reason for Test: To determine if the device meets the American Academy of Pediatrics recommended level for "intense phototherapy" (>30 µW/cm²/nm) and the IEC 60601-2-50 light distribution standard (Ebi min / Ebi max > 0,4).
Test Performed: A Bright Embrace prototype Model SBL60 was tested using a newly calibrated Natus neoBLUE LED Phototherapy radiometer. The device was turned on and wrapped into the normal use position. The sensor head of the light meter was placed against the clear plastic inner surface of the device. 30 measurements were taken from 10 adjacent LED "spotlights" (in a 2 x 5 grid) representing 8% of the 126 LED "spotlights". The average irradiance, the minimum (Ebi min), and the maximum (Ebi max) irradiances, and the distribution (Ebi min' / Ebi max) were determined.
Test Results: Total Average Irradiance: 38.36 µW/cm²/nm. Range of irradiance: Ebi min = 26 µW/cm²/nm to Ebi max = 57 µW/cm²/nm. Distribution: Ebi min / Ebi max = 26 / 57 = 0.46.
Conclusions: The average irradiance meets AAP guidelines for "intense phototherapy". The phototherapy light distribution meets the IEC 60601-2-50 standard.
B.2. Body Surface Area (BSA) test: Lab Test Form, Date: 1/10/2011, Product: Bright Embrace Model SBL60.
Reason for Test: To determine what newborn body surface area (BSA) is treated with phototherapy by the device, as AAP recommends "as much BSA as possible".
Test Performed: A term-sized neonatal manikin was wrapped inside the Bright Embrace prototype Model SBL60 and the unit turned on. Areas of the body parts visibly lit by the blue light "spotlights" of the 126 LED bulbs were recorded. The area of each spotlight hitting the manikin was measured. Total BSA treated was calculated by multiplying the number of spotlights by the surface area treated by each, then divided by the BSA of a standard newborn BSA (1800 cm²). The test was repeated with a premature-sized infant (premie) manikin.
Test Results: Normal manikin: 126 LEDs lighting manikin x 3.98 cm² = 501 cm² BSA treated. Normal-size newborn % BSA treated: 501 cm² / 1800 cm² = 28%. Premie manikin: 120 LEDs lighting manikin x 3.98 cm² = 478 cm² BSA treated. Premie-size newborn % BSA treated: 478 cm² / 1300 cm² = 37%.
Conclusions: The device provides treatment to the desirable BSA of an average term newborn and an average premature newborn.
B.3. Temperature test: Lab Test Form, Product: Bright Embrace Model SBL60, Title: Operating Temperature Test.
Reason for Test: To determine that the heat generated by the device is in an acceptable, safe range, meeting the IEC 60601-2-50 standard of not exceeding 40°C at any location that touches the newborn.
Test Performed: A Bright Embrace prototype Model SBL60 was tested using an Omega Model 450 digital thermometer with an air sensor. The device was turned on and rolled into the tubular position of normal use. The temperature sensor was placed directly over an LED "spotlight" on the device in 12 locations. Temperatures were measured and recorded after 120 minutes for equilibration.
Test Results: Maximum temperature observed was 31.7 / 31.9 °C (with Softy).
Conclusions: Average temperature of 27-29 °C (81-84°F) is in the acceptable range for unclad babies. No temperatures exceeded the 40 °C (104°F) limit, meeting the 60601-2-50 standard. The thermal environment is safe.
B.4. Environmental Temperature/Humidity test: Lab Test Form, Product: Bright Embrace Model SBL60, Title: Storage Temperature Test.
Reason for Test: To determine if the environmental storage limits of the power supply (-5°C to 60°C; 0-90% rH) are appropriate for the entire device.
Test Performed: Two prototype devices (light source, power supply, Softy, Bili-Goggles) were placed in temperature-controlled containers: one freezer at -5°C (23°F) and one incubator at 60°C (140°F), both at 90% rH, for 60 days each. After 60 days, devices were tested for defects (visual observation) and function (turning on/off 10 times, measuring irradiance at 0 and 4 hours).
Test Results: No visual defects after folding/unfolding. Power supply, Softy, and Bili-Goggles appeared undamaged. Devices turned on and off without failure. Irradiance readings were the same as prior to storage.
Conclusion: The environmental storage temperature limits specified by the power supply are appropriate for the entire device.
B.5. Leakage test: Lab Test Form, Product: SBL60, Title: SBL60 Leakage Test.
Reason for Test: To determine the appropriate medical device applied parts Type (B, BF, or CF).
Test Performed: An SBL60 working prototype was tested with a BC Biomedical SA-2000 Safety Analyzer in all configurations and the µAmps or ohms were recorded. Readings were compared to leakage requirements for Type B, BF, and CF standards.
Test Results: Leakage tests were all at 000 µA, and Earth Resistance at 1 Ω in all configurations.
Conclusions: The SBL60 qualifies for applied parts Type CF.
Clinical testing:
Since the treatment of neonatal hyperbilirubinemia with blue light phototherapy is a wellestablished clinical practice, clinical or animal testing to demonstrate safety and effectiveness is not necessary.
Key Metrics
Not Found
Predicate Device(s)
Physician Engineered Products, Inc. -- Ultra Bili Light (K974830)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5700 Neonatal phototherapy unit.
(a)
Identification. A neonatal phototherapy unit is a device used to treat or prevent hyperbilirubinemia (elevated serum bilirubin level). The device consists of one or more lamps that emit a specific spectral band of light, under which an infant is placed for therapy. This generic type of device may include supports for the patient and equipment and component parts.(b)
Classification. Class II (performance standards).
0
FEB - 3 2012
510(k) Summary
| Submitter: | Physician Engineered Products, Inc.
103 Smith Street
Fryeburg, ME 04037 |
|----------------------|------------------------------------------------------------------------------------|
| Contact Person: | Robert Rose, MD
CEO
207-935-1256
Fax – 207-935-1257
rose@peponline.com |
| Date prepared: | 1/14/2011 |
| Proprietary Name: | Bright Embrace Model SBL60 |
| Common Name: | Neonatal Phototherapy Light |
| Classification Name: | Unit, Neonatal Phototherapy |
| Regulation number: | 21 CFR 880.5700 |
Classification: Class II
Product Code: LBI
Physician Engineered Products, Inc. -- Ultra Bili Light (K974830) Predicate Device:
Device Description:
The Bright Embrace Model SBL60 is a single-patient, portable phototherapy light that was specifically designed to incorporate these features:
-
- high intensity blue light over a large body surface area as recommended by the American Academy of Pediatrics (AAP);
-
- the ability to hold the newborn during treatment;
-
- single patient use to minimize cross-contamination in hospitals and to facilitate home care logistics:
The Bright Embrace Model SBL60 delivers a narrow band of high-intensity blue light via blue light emitting diodes (LEDs) to provide treatment for neonatal hyperbilirubinemia, also called newborn jaundice. The Bright Embrace Model SBL60 is designed to provide phototherapy treatment from a wrap-around design that provides light from underneath, the sides and partially the front of the newborn to achieve a large body surface area of treatment.
The blue LEDs used in the Bright Embrace Model SBL60 emit light in the range of 430-510nm (peak wavelength 480nm). This range corresponds to the spectral absorption of light by bilirubin, and is thus considered to be the most effective for the desirable degradation of bilirubin under the exposed skin. Blue LEDs do not emit significant energy in the ultraviolet (UV) region of the spectrum, so there is no concern about UV exposure to the newborn. As with most phototherapy devices, protective eye shades or goggles must be used to protect the newborn's eyes from excessive light exposure.
1
Since LEDs have minimal light output degradation over 10,000 hours (with proper use), and since the Bright Embrace Model SBL60 is designed for single patient use of 60 hours of phototherapy or less, there is no significant decradation of light output over the life-span of the Bright Embrace Model SBL60.
The irradiance by the Bright Embrace Model SBL60 to the newborn's skin averages 38 uWcm²/nm - nicely in the range for "intense phototherapy" recommended by the AAP of >30 uWcm3/nm. The body surface area (BSA) treated by these lights covers 501 cm², or 21% of the BSA of an average size newborn - consistent with the AAP recommendation to treat "as much body surface area as possible."
A newborn being treated in a Bright Embrace Model SBL60 can be held for feeding or cuddling during treatment. Otherwise, it is recommended that the Bright Embrace Model SBL60 and newborn be placed in a crib or bassinette or on a warming table or in an incubator for security.
The sincle-patient design of the Bright Embrace Model SBL60 virtually eliminates the risk of cross-contamination between newborns. The newborn is swaddled in a light-transmitting. disposable non-woven spun-bound material "Softy" for comfort and cleanliness. The baby and Softy swaddling overlie a clear PVC (nonreactive) plastic tray that overlies the LEDs and the electronic circuitry including an hour meter. The back of the device is soft, flexible, nonabsorbent neoprene.
60 hours was determined to be an appropriate maximum for this single use device. Based on non-published PEP outcome studies with the similar-dose device, the PEP Ultra Bili Light, over 95% of newborns requiring phototherapy need less than 60 hours. After searching medical publications and literature available from other phototherapy device manufacturers, no other treatment times data could be found or is known.
The hour meter timing control built into the Bright Embrace Model SBL60 is simply a LCD display that shows the hours left on the machine. It is set at manufacture to 60 hours and counts backward when the unit is on until phototherapy is completed or until the timing control reaches zero hours, at which point the unit will no longer light. It's purpose is to ensure the single-patient intent of the device; it does not control or determine the treatment time of the newborn. The simple timer programming circuitry contains minimal software.
The Bright Embrace Model SBL60 system consists of 4 components: the light source, the lowvoltage power supply, disposable "Softy" swaddling material, and Bill-Goggles (or other eye protection). In addition, there are included instructions for use and a mail-back box for green recycling.
Intended Use:
The Bright Embrace Model SBL60 phototherapy light is intended for the treatment of neonatal hyperbilirubinemia. It is designed to provide phototherapy treatment from underneath and around the newborn. The Bright Embrace Model SBL60 can be used in a clinical setting or in the home.
Comparison with Predicate Devices:
The Bright Embrace Model SBL60 and the Ultra Bili Light have the same intended use of treatment of neonatal hyperbilirubinemia and use the same operating principle of delivering briaht blue light to degrade bilirubin. The Ultra Bili Light is chosen as a predicate because: 1) it is PEP's other neonatal phototherapy device; 2) it provides "intense phototherapy" (as defined by the AAP) to a large body surface area – as does the Bright Embrace Model SBL60. See the Comparison Table below for details:
2
| Device Comparison Table | PEP Bright Embrace
Model SBL60 | PEP Ultra Bili Light
(K974830) |
|--------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------|
| Feature: | | |
| Intended Use | For treatment of neonatal
hyperbilirubinemia | For treatment of neonatal
hyperbilirubinemia |
| Treatment Method | Around newborn phototherapy | Overhead and side of
newborn phototherapy |
| Target Population | Neonates | Neonates |
| Sites of Use | Clinical setting, home-use | Clinical setting, home-use |
| Specifications: | | |
| Type of Device | Free standing device | Free standing device |
| Type of Light | Blue light LED | Blue light fluorescent |
| Intensity average | 38 µW/cm²/nm | 60 µW/cm²/nm |
| Dimensions | 43cm long x
48cm wide x
5cm high | 46cm long x
58cm wide x
46cm high |
| Weight | 0.55 kg (1.2 lb) | 6.5 kg (14 lb) |
| Treatment area as % of
newborn body surface area
(BSA) | 501 cm² - 21% of BSA | 960 cm² - 40% of BSA |
| Phototherapy Treatment Units
(PTUs) = irradiance x BSA | $38 µW/cm²/nm x 21% BSA =800 PTUs$ | $60 µW/cm²/nm x 40% BSA =2400 PTUs$ |
| Materials: | | |
| Device | PVC enclosure with neoprene
back | Polyethylene case |
| Mattress | na | Vinyl covered foam cushion |
| Patient contact | Nonwoven spunlaced
polyester fabric | Nonwoven spunlaced
polyester pad |
| Miscellaneous: | | |
| Shape | Tubular around newborn | Rectangular suitcase style |
| Portable | Yes | Yes |
| Use Intent | Single-Patient | Multi-Patient |
| Duration of Treatment | Expect under 60 hours | 28 hr. average, 95% 95% Dip for
0.5 Cycle
60% Dip for
5 Cycles
30% Dip for
25 Cycles
95% Dip
for 5
Seconds | >95% Dip for
0.5 Cycle
60% Dip for
5 Cycles
30% Dip for
25 Cycles
95% Dip for
5 Seconds | Mains power quality should be at least that of a typical commercial or hospital environment. If the user of the SBL60 requires continued operation during power mains interruptions, it is recommended that the SBL60 be powered from an uninterruptible power supply or battery. |
| Power Frequency
50/60 Hz
Magnetic Field
EN/IEC 61000-4-8 | 3A/m | 3A/m | Power frequency magnetic fields should be that of a typical commercial or hospital environment. |
Guidance and Manufacturer's Declaration – Emissions – Equipment and Systems that are NOT Life-Supporting
The SBL60 is intended for use in the electromagnetic environment specified below. The customer or user of the SBL60 should ensure that it is used in such an environ.
| Immunity Test | EN/IEC 60601
Test Level | Compliance
Level | Electromagnetic
Environment -
Guidance |
|----------------------------------|-----------------------------|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Conducted RF
EN/IEC 61000-4-6 | 3 Vrms
150 kHz to 80 MHz | (3) Vrms | Portable and mobile
communications
equipment should
be separated from
the SBL60 by no
less than the
distances
calculated/listed
below: |
| Radiated RF
EN/IEC 61000-4- | 3V/m
80 MHz to 2.5 | (3) V/m | D=(3.5/V1)(Sqrt P)
80 to 800 MHz |
7
| 3 | GHz | |
|---|---|---|
| D=(7/E1)( $Sqrt P$ ) | ||
| 800 MHz to 2.5 GHz | ||
| Where P is the max | ||
| power in watts and | ||
| D is the | ||
| recommended | ||
| separation distance | ||
| in meters. | ||
| Fields strength from | ||
| fixed transmitters, | ||
| as determined by an | ||
| electromagnetic site | ||
| survey, should be | ||
| less than the | ||
| compliance levels | ||
| (V1 and E1) | ||
| Interference may | ||
| occur in the vicinity | ||
| of equipment | ||
| containing a | ||
| transmitter. |
Recommended Separations Distances for the SBL60 - Equipment and Systems that are NOT Life-Supporting
The SBL60 is intended for use in the electromagnetic environment in which the radiated disturbances are controlled. The customer or user can help prevent electromagnetic interference by maintaining a minimum distance between portable and mobile RF Communications Equipment and the SBL60 as recommended below, according to the maximum output power of the communications equipment
| Max Output | Separation (m) | Separation (m) | Separation (m) |
|---|---|---|---|
| Power (Watts) | 150kHz to 80MHz | 80 to 800 MHz | 800MHz to 2.5Ghz |
| D= $(3.5/V1)(Sqrt P)$ | D= $(3.5/E1)(Sqrt P)$ | D= $(7/E1)(Sqrt P)$ | |
| 0.01 | .1166 | .1166 | .2333 |
| 0.1 | .3689 | .3689 | .7378 |
| 1 | 1.1666 | 1.1666 | 2.3333 |
| 10 | 3.6893 | 3.6893 | 7.3786 |
| 100 | 11.6666 | 11.6666 | 23.3333 |
Radiation Safety: IEC 60601-1-2:2004; LED light source emits no UV light -
A.3. IEC 60601-2-50: 2000/07/01 Ed:1 - Particular Requirements for the Safety of Infant (sic) Phototherapy Equipment. This Safety standard testing was completed on the Bright Embrace Model SBL60 device by Intertek, a certified standards testing laboratory. See Attachment A-3.
8
B. Tests Performed at Physician Engineered Products, Inc.:
B.1. Irradiance test:
Lab Test Form
Product: Bright Embrace Model SBL60 Date: 6/10/11
Irradiance test of Bright Embrace Model SBL60
Reason for Test (explain in detail):
The Bright Embrace prototype Model SBL60 is tested for blue light irradiance to determine if: 1) it meets the American Academy of Pediatrics recommended level for "intense phototherapy" - over 30 µW/cm2/nm²/nm;
- it meets the IEC 60601-2-50 light distribution standard of Ebi min / Ebi max > 0,4
Test Performed:
-
A Bright Embrace prototype Model SBL60 is tested using a newly calibrated Natus neoBLUE LED Phototherapy radiometer;
-
The device is turned on and wrapped into the normal use position (as if wrapped around a newborn receiving phototherapy);
-
The sensor head of the light meter is placed against the clear plastic inner surface of the device and aimed at the light source – simulating the light as it would hit the newborn's skin; 4) 30 measurements are taken from 10 adjacent LED "spotlights" (in a 2 x 5 grid) representing 8% of the 126 LED "spotlights". The 2.25 cm. diameter "spotlights" are divided into 3 concentric rings - each ring with a width of 0.375 cm - Ring 1 from 0-0.375 cm from center; Ring 2 from 0.375-0.75 cm from center; Ring 3 from 0.75-1.125 cm from center. Irradiance measurements are taken at points 0 cm., 0.5 cm. from the center of the "spotlights" to accurately represent irradiance readings in each ring. The average irradiance, the minimum (Ebi min), and the maximum (Ebi max) irradiances, and the distribution (Ebi min' / Ebi max) are determined;
| Test Results: Irradiance (µW/cm²/nm) | Area (cm²) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| "Spotlight": | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Avg | % | ||
| Ring 1: | 57 | 56 | 55 | 56 | 56 | 54 | 56 | 52 | 57 | 55 | 55.4 | 0.44 | 11 | |
| Ring 2: | 50 | 45 | 54 | 45 | 48 | 48 | 50 | 44 | 53 | 49 | 48.6 | 1.16 | 29 | |
| Ring 3: | 33 | 29 | 35 | 29 | 29 | 29 | 32 | 26 | 33 | 28 | 30.3 | 2.38 | 60 | |
| Total | 3.98 | 100 | ||||||||||||
| Calculate: | Avg. irradiance | x % of "spotlight" | = share of irradiance | |||||||||||
| Ring 1: | 55.4 | x | .11 | = | 6.09 | |||||||||
| Ring 2: | 48.6 | x | .29 | = | 14.09 | |||||||||
| Ring 3: | 30.3 | x | .60 | = | 18.18 | |||||||||
| Total Average Irradiance: | 38.36 µW/cm²/nm | |||||||||||||
| Total BSA: | ||||||||||||||
| % BSA: | 3.98 cm²/"spotlight" x 126 "spotlights" = | |||||||||||||
| 501 cm² / 1800 cm² (average newborn BSA) = | 501 cm² | |||||||||||||
| 28% BSA | ||||||||||||||
| 1) Average irradiance: | 38 µW/cm²/nm | |||||||||||||
| 2) Range of irradiance: | Ebi min = 26 µW/cm²/nm to | |||||||||||||
| Ebi max = 57 µW/cm²/nm |
- Distribution: Ebi min / Ebi max = 26 / 57 = 0.46
9
Pass / Fail criteria:
-
Irradiance average at or over 30μW/cm²/nm;
-
Distribution: >0.4
Conclusions:
-
The average irradiance of the Bright Embrace Model SBL 60 meets the AAP guidelines for "intense phototherapy";
-
The phototherapy light distribution of the Bright Embrace Model SBL 60 meets the IEC 60601-2-50 light distribution standard.
10
B.2. Body Surface Area (BSA) test:
Lab Test Form
Date: 1/10/2011 Product: Bright Embrace Model SBL60_
Reason for Test (explain in detail):
The purpose of this test is to determine what newborn body surface area (BSA) is treated with phototherapy by the Bright Embrace Model SBL60. The AAP recommends "intense phototherapy" to "as much BSA as possible". Therefore, it is important to determine what % BSA is being treated by the Bright Embrace Model SBL60.
Test Performed:
A term-sized neonatal manikin is wrapped inside the Bright Embrace prototype Model SBL60 and the unit turned on. Areas of the body parts of the manikin - head, neck, trunk, arms, legs, genital area – that are visibly lit by the blue light "spotlights" of the 126 LED bulbs in the Bright Embrace are recorded. The area or each spotlight that hits the manikin is then measured. By multiplying the # of spotlights x the surface area treated by each, a total BSA treated can be calculated. This area is then divided by the BSA of a standard newborn BSA (1800 cm²) to determine what % of the total BSA is treated by the Bright Embrace Model SBL60.
The test was then repeated using a premature-sized infant (premie) manikin and the area is then divided by the BSA of a standard premie BSA (1to determine what % of the total BSA is treated by the Bright Embrace Model SBL60.
| Test Results: | Spotlight area: 2.25 cm diameter = 3.98 cm² | |
|---|---|---|
| Normal manikin: | # LEDs lighting manikin | x 3.98 cm² = BSA treated |
| 126 | x 3.98 cm² = 501 cm² | |
| Premie manikin: | # LEDs lighting manikin | x 3.98 cm² = BSA treated |
| 120 | x 3.98 cm² = 478 cm² | |
| Calculate: | normal-size newborn % BSA treated: | 501 cm² / 1800 cm² = 28% |
| Total % BSA of normal-size newborn treated by the Bright Embrace = 28% | ||
| premie-size newborn % BSA treated: | 478 cm² / 1300 cm² = 37% | |
| Total % BSA of premie-size newborn treated by the Bright Embrace = 37% |
Pass / Fail criteria: > 20% BSA desirable
Conclusions:
-
The Bright Embrace Model SBL60 provides treatment to the desirable BSA of an average term newborn:
-
The Bright Embrace Model SBL60 provides treatment to the desirable BSA of an average premature newborn.
11
B.3. Temperature test:
Lab Test Form
Product:
Operating Temperature Test:
Reason for Test (explain in detail):
The LED light source in the Bright Embrace Model SBL60 generates some heat. This test is to determine that the heat generated by the device is in an acceptable, safe range - i.e., that it meets the IEC 60601-2-50 standard of not exceeding 40°C at any location that touches the newborn.
Test Performed:
-
A Bright Embrace prototype Model SBL60 is tested using an Omega Model 450 digital thermometer using the air sensor;
-
The device with and without a Softy attached is turned on and rolled into the tubular position of normal use - as if wrapped around a newborn;
-
The temperature sensor is placed directly over an LED "spotlight" on the Bright Embrace Model SBL60 in 12 locations: at the left, back and right sides at mid-head, mid-chest, midabdomen and knee levels;
-
Allowing 120 minutes at each location for equilibration, the temperature is measured and recorded.
| °C - air / surface | ||
|---|---|---|
| Site: | With Softy | Without |
| Softy | ||
| left ear | 30.0 / 25.0 | 23.5 / 26.6 |
| occiput | 25.8 / 24.9 | 23.9 / 26.5 |
| right ear | 28.1 / 24.8 | 25.3 / 26.8 |
| left chest | 29.4 / 29.3 | 29.7 / 31.6 |
| back chest | 30.5 / 32.8 | 30.0 / 31.5 |
| right chest | 27.8 / 26.5 | 28.6 / 31.1 |
| left abdomen | 28.1 / 30.1 | 30.1 / 31.2 |
| back abdomen | 31.7 / 31.9 | 29.3 / 29.3 |
| right abdomen | 27.1 / 29.4 | 28.9 / 30.3 |
| left side knee | 24.9 / 26.3 | 27.3 / 28.9 |
| back of knee | 23.2 / 24.8 | 26.8 / 27.5 |
| right side knee | 26.9 / 26.1 | 28.3 / 29.9 |
| Average | 27.8 / 27.7 | 27.6 / 29.3 |
| Ambient | 22.2 / 22.1 | 22.7 / 23.4 |
| Maximum | 31.7 / 31.9 | 30.1 / 31.2 |
Test Results:
Pass / Fail criteria: no location > 40°C.
Conclusions:
-
- Average temperature of 27-29 °C (81-84°F) is in the acceptable range for unclad babies. .
-
- No temperatures exceeded the 40 °C (104°F) limit the 60601-2-50 standard is met.
-
- The thermal environment inside the Bright Embrace Model SBL 60 is safe.
12
B.4. Environmental Temperature/Humidity test: Lab Test Form
Bright Embrace Model SBL60 Date: Product:
Storage Temperature Test
Reason for Test (explain in detail):
The Bright Embrace Model SBL60 may be stored under a variety of environmental circumstances. The power supply - Glob-Tek Model GTM41060-2515 - is rated to these environmental storage limits:
Temperature: low limit = -5°C (23°F); high limit = 60°C (140°F);
Humidity: 0-90% rH
The purpose of this test is to determine if these limits are appropriate for the entire Bright Embrace Model SBL60 device.
Test Performed:
-
Two Bright Embrace Model SBL60 prototype devices - including: the light source, the power supply, the Softy and the Bili-Goagles are placed in 2 temperature-controlled containers - one freezer set to -5°C (23°F) and one incubator set to 60°C (140°F) - both at 90% rH - for 60 days each.
-
After the 60 days, the 2 devices are tested for:
defects - by visual observation of all four components:
-
the light source after folding and unfolding the device into the wrapped position 10 times:
-
the power supply by visual check of cord and supply:
-
the Softy, and
-
the Bili-Goggles
function - turning on and off the device 10 times, and
- measuring the irradiance at zero hours and 4 hours.
Test Results:
-
Neither of the two Bright Embrace Model SBL60 prototype devices revealed any visual defects after 10 foldings and unfoldings. The power supply, Softy and Bili-Goggles appeared undamaged.
-
The devices turned on and off 10 times each without failure;
-
The irradiance readings at 0 hours and 4 hours are the same as prior to storage.
Conclusion:
- The Environmental Storage Temperature Limits specified by the power supply - Glob-Tek Model GTM41060-2515 - are appropriate for the entire Bright Embrace Model SBL60 device.
13
B.5. Leakage test:
Lab Test Form
Product: _____________________________________________________________________________________________________________________________________________________________________
Title: SBL60 Leakage Test
Reason for Test (explain in detail):
Leakage testing is needed to determine the appropriate medical device applied parts Type – B or BF or CF
Test Performed:
An SBL60 working prototype is tested with a BC Biomedical SA-2000 Safety Analyzer in all configurations and the µAmps or ohms are recorded. These readings are then compared to the leakage requirements for the applied parts Type B, BF and CF standards.
Test Results:
| Enclosure: | Hot: | Neutral: | Ground: | Polarity: | μA: |
|---|---|---|---|---|---|
| closed | closed | closed | FWD | 000 | |
| closed | closed | closed | REV | 000 | |
| open | closed | closed | FWD | 000 | |
| open | closed | closed | REV | 000 | |
| closed | open | closed | FWD | 000 | |
| closed | open | closed | REV | 000 | |
| open | open | closed | FWD | 000 | |
| open | open | closed | REV | 000 | |
| Earth/Ground: | closed | closed | open | FWD | 000 |
| closed | closed | open | REV | 000 | |
| open | closed | open | FWD | 000 | |
| open | closed | open | REV | 000 | |
| closed | open | open | FWD | 000 | |
| closed | open | open | REV | 000 | |
| open | open | open | FWD | 000 | |
| open | open | open | REV | 000 |
14
| Hot: | Neutral: | Ground: | Polarity: | Ω | |
|---|---|---|---|---|---|
| Earth Resistance: | closed | closed | closed | FWD | 1 |
| closed | closed | closed | REV | 1 | |
| open | closed | closed | FWD | 1 | |
| open | closed | closed | REV | 1 | |
| closed | open | closed | FWD | 1 | |
| closed | open | closed | REV | 1 | |
| open | open | closed | FWD | 1 | |
| open | open | closed | REV | 1 |
Pass / Fail Criteria:
| Applied Parts Type: | B | BF | CF (normal/single fault) |
|---|---|---|---|
| (µA) Enclosure: | 100/500 | 100/500 | 100/500 |
| Ground: | 500/1000 | 500/1000 | 500/1000 |
| Patient: | 100/500 | 100/500 | 10/50 |
Conclusions:
-
Leakage tests are all at 000 µA.
-
The SBL60 qualifies for applied parts Type CF.
15
Summary of Non-Clinical Testing:
The Medical Electrical Equipment Safety standard IEC 60601-1 for the power supply and the entire device is met.
The Electromagnetic Conductance (EMC) standard IEC 60601-1-2 for the device is met. The Particular Requirements for the Safety of Infant (sic) Phototherapy Equipment standard IEC 60601-2-50 is met.
This submission includes the results of testing of prototype devices to specifications ~ including irradiance, BSA, temperature and environmental conditions, and leakage testing. The results were as expected, and no new issues of safety or effectiveness were raised as a result of this testing.
Clinical testing:
Since the treatment of neonatal hyperbilirubinemia with blue light phototherapy is a wellestablished clinical practice, clinical or animal testing to demonstrate safety and effectiveness is not necessary.
Conclusions:
Based on the data and the information presented in this submission, the Bright Embrace Model SBL60 has undergone and passed more standards testing than the predicate - ensuring the Bright Embrace Model SBL60 is at least as safe as the predicate. In addition, the irradiance and BSA tests document that the Bright Embrace Model SBL60 treatment light dose is substantially equivalent to the currently marketed predicate Ultra Bili Light light dose. Therefore, the Bright Embrace Model SBL60 is substantially equivalent to the predicate.
16
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/16/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo is circular, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. Inside the circle is a stylized image of an eagle or bird-like figure, with three curved lines representing its wings or body.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Dr. Robert Rose Physician Engineered Products, Incorporated 103 Smith Street Fryeburg, Maine 04037
FEB - 3 2012
Re: K110550
Trade/Device Name: Bright Embrace Model SBL60 Regulation Number: 21 CFR 880.5700 Regulation Name: Neonatal Phototherapy Unit Regulatory Class: II Product Code: LBI Dated: December 28, 2011 Received: January 10, 2012
Dear Dr. Rose:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
17
Page 2 – Dr. Rose
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices /ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
G for Anthony d. Watson
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
18
Indications for Use
510(k) Number (if known): K110550
Device Name: Bright Embrace Model SBL60
Indications for Use:
The Bright Embrace Model SBL60 phototherapy light is intended for the treatment of neonatal hyperbilirubinemia. It is designed to provide phototherapy treatment from underneath and around the neonate. The Bright Embrace can be used in a clinical setting or in the home.
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Ri Cdm
(Division Sign-Ufi) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: K110550
Page 1 of ____________________________________________________________________________________________________________________________________________________________________